Prevalence of Sjögren’s syndrome associated with rheumatoid arthritis in the USA: an observational study from the Corrona registry

• Published in: Clinical rheumatology 2020-06, Vol.39 (6), p.1899-1905
• Main Authors: Harrold, Leslie R., Shan, Ying, Rebello, Sabrina, Kramer, Neil, Connolly, Sean E., Alemao, Evo, Kelly, Sheila, Kremer, Joel M., Rosenstein, Elliot D.
• Format: Article
• Language: English
• Subjects: Aged; Arthritis, Rheumatoid - complications; Arthritis, Rheumatoid - epidemiology; Brief Report; Cardiovascular diseases; Female; Health risk assessment; Health Status; Humans; Male; Medicine; Medicine & Public Health; Middle Aged; Nodules; Observational studies; Prevalence; Prospective Studies; Registries; Rheumatoid arthritis; Rheumatology; Sjogren's syndrome; Sjogren's Syndrome - complications; Sjogren's Syndrome - epidemiology; United States - epidemiology
• ISSN: 0770-3198; 1434-9949
• DOI: 10.1007/s10067-020-05004-8

The objectives of this analysis were to assess the prevalence of Sjögren’s syndrome (SS) associated with rheumatoid arthritis (RA) and to compare baseline characteristics of patients with RA with and without SS. Adult patients with RA from a large observational US registry (Corrona RA), with ≥ 1 visit for assessment of SS status between 22 April 2010 and 28 February 2018, were considered. Patients with RA with versus without SS were compared. SS status was determined from a yes/no variable and reported at enrollment into the Corrona RA registry and follow-up visits. Outcomes were unadjusted prevalence of SS in patients with RA, prevalence of SS by RA disease duration, and baseline characteristics in patients with RA by SS status. Of 24,528 eligible patients, 7870 (32.1%) had a diagnosis of RA and SS. The unadjusted overall rate for SS prevalence in patients with RA was 0.30 (95% confidence interval 0.29, 0.31). SS prevalence increased with increasing RA duration. Patients with RA with versus without SS were more likely to be older, female, and seropositive; had a longer RA duration; higher disease activity; and a higher incidence of comorbidities (hypertension, cardiovascular disease, malignancies, and serious infections), erosive disease, and subcutaneous nodules at index date. Patients with RA and SS had a higher disease burden than those with RA only. The prevalence of SS increased as duration of RA increased. RA with SS was associated with seropositivity, more severe RA, extra-articular manifestations, and comorbidities. Key Points • The overall prevalence of SS among patients with RA was 30%. • The prevalence of SS increased with increasing RA disease duration. • Identifying specific clinical characteristics of patients with RA with SS, such as a greater incidence of extra-articular manifestations and comorbidities, may help clinicians to better characterize this patient population.